Related Experiment Video
Updated: Feb 19, 2026
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
12.1K
Evaluating the Changing Financial Burdens for Graduating Pharmacists
T Joseph Mattingly1, Timothy R Ulbrich2
1University of Maryland School of Pharmacy, Baltimore, Maryland.
American Journal of Pharmaceutical Education
|November 8, 2017
Summary
New pharmacists earned less net income in 2014 than in 2009, despite higher salaries. Increased consumer spending reduced discretionary income for pharmacy graduates, impacting overall financial well-being.
Area of Science:
- Health Economics
- Pharmacy Practice
Background:
- Recent pharmacy graduates' financial well-being is crucial for workforce sustainability.
- Understanding income trends is vital for career planning and policy development.
Purpose of the Study:
- To compare the net income of new pharmacy practitioners in 2009 versus 2014.
- To model financial outcomes using salary, expenditure, and student loan data.
Main Methods:
- A Monte Carlo simulation with probabilistic sensitivity analysis was employed.
- Student t-tests were used to compare mean differences between the 2009 and 2014 cohorts.
- Data included pharmacist salary, consumer expenditures, and student loan information.
Main Results:
- Pharmacist salaries and disposable income were higher in 2014 than in 2009.
- Increased consumer expenditures in 2014 led to lower discretionary income compared to 2009.
- Net income decreased for all pharmacy school graduates from 2009 to 2014.
Conclusions:
- Pharmacists graduating in 2014 experienced lower net incomes than those graduating in 2009.
- This trend was observed across all pharmacy school types, irrespective of loan repayment strategies.
Related Concept Videos
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
272
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
272
01:15Drug Dosing: Geriatric Patients
289
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
289
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
265
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
265
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
741
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
741
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
24
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
24
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
217
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
217